Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009
Level of serum procalcitonin and pneumonia risk classes Source: Annual Congress 2009 - Pulmonary infections Year: 2009
Procalcitonin and C-reactive protein levels correlate worse with organ failure than NT-proBNP levels in septic patients Source: Eur Respir J 2006; 28: Suppl. 50, 61s Year: 2006
Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis? Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004
Evaluation of the relationship between KIM-1 and suPAR level in COVID-19 patients and a different perspective on suPAR Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science Year: 2021
High serum levels of YKL-40 in IPF Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
The relation of serum interleukin-6 and C-reactive protein to clinical parameters in pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004
Clinical significance of serum adipokines levels in lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005
Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017
Clinical significance of serum osteopontin levels in lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
The relationship between the serum YKL-40 level and severity of asthma Source: Annual Congress 2012 - Asthma management Year: 2012
High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Is there a relationship between severity of COPD and C-reactive protein (CRP) levels? Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006
Circulating total leptin as a diagnostic and prognostic biomarker in sepsis Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019
Prognostic significance of plasma D-dimer (DD) in lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002
Serum procalcitonin and C-reactive protein in children with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 488s Year: 2006
Serum ferritin as a prognostic marker of pneumonia: a prospective, single center study Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018
Diagnostic importance of quantitative evaluation of plasma CRP in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004